These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 19562524)
21. Antiphospholipid syndrome. George D; Erkan D Prog Cardiovasc Dis; 2009; 52(2):115-25. PubMed ID: 19732604 [TBL] [Abstract][Full Text] [Related]
22. Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view. Meroni PL; Tedesco F; Locati M; Vecchi A; Di Simone N; Acaia B; Pierangeli SS; Borghi MO Lupus; 2010 Apr; 19(4):453-6. PubMed ID: 20353987 [TBL] [Abstract][Full Text] [Related]
25. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Meroni PL; Gerosa M; Raschi E; Scurati S; Grossi C; Borghi MO Clin Rev Allergy Immunol; 2008 Jun; 34(3):332-7. PubMed ID: 18175073 [TBL] [Abstract][Full Text] [Related]
26. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Forastiero R; Martinuzzo M Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486 [TBL] [Abstract][Full Text] [Related]
27. The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Chighizola CB; Andreoli L; de Jesus GR; Banzato A; Pons-Estel GJ; Erkan D; Lupus; 2015 Aug; 24(9):980-4. PubMed ID: 25697769 [TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid Syndrome and the Kidney. Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550 [TBL] [Abstract][Full Text] [Related]
29. CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages. Samudra AN; Dwyer KM; Selan C; Freddi S; Murray-Segal L; Nikpour M; Hickey MJ; Peter K; Robson SC; Sashindranath M; Cowan PJ; Nandurkar HH J Autoimmun; 2018 Mar; 88():131-138. PubMed ID: 29103803 [TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid syndrome: critical analysis of the diagnostic path. Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982 [TBL] [Abstract][Full Text] [Related]
31. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
32. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Ernest JM; Marshburn PB; Kutteh WH Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465 [TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies. Cervera R; Espinosa G Expert Opin Ther Targets; 2010 Dec; 14(12):1279-82. PubMed ID: 21058919 [TBL] [Abstract][Full Text] [Related]
38. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome. Staub HL; Bertolaccini ML; Khamashta MA Autoimmun Rev; 2012 Dec; 12(2):230-4. PubMed ID: 22796282 [TBL] [Abstract][Full Text] [Related]
40. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. Chauleur C; Galanaud JP; Alonso S; Cochery-Nouvellon E; Balducchi JP; Marès P; Fabbro-Peray P; Gris JC J Thromb Haemost; 2010 Apr; 8(4):699-706. PubMed ID: 20088936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]